Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 8Sanofi-Aventis Canada Inc.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 2174338
Filing Date : 1995-08-30
Strength per Unit : 5 mg / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 2174338
Filing Date : 1995-08-30
Strength per Unit : 2.5 mg/ 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 5 mg / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5 mg / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-11-26
Date Granted : 2002-11-12
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 2055948
Filing Date : 1991-11-26
Strength per Unit : 5 mg / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-11-26
Date Granted : 2002-11-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 2.5 mg/ 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.5 mg/ 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-11-26
Date Granted : 2002-11-12
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 2055948
Filing Date : 1991-11-26
Strength per Unit : 2.5 mg/ 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-11-26
Date Granted : 2002-11-12
